Managing chronic hepatitis C in primary-care settings: More than antiviral therapy

Public Health Reports

Volumn 122, Issue SUPPL. 2, 2007, Pages 78-82

  Zevin, Barry ^a  

^a SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; PEGINTERFERON; PROTEINASE INHIBITOR; RIBAVIRIN;

ANAMNESIS; ANEMIA; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; DEPRESSION; DISEASE TRANSMISSION; DRUG INDUSTRY; FLU LIKE SYNDROME; FUNDING; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEPATITIS C; HUMAN; INFECTION PREVENTION; MEDICAL SPECIALIST; PATIENT CARE; PREVALENCE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; STIGMA; UNITED STATES; ARTICLE; ECONOMICS; HUMAN RELATION; ORGANIZATION AND MANAGEMENT; PATIENT EDUCATION; SOCIAL PSYCHOLOGY;

ANTIVIRAL AGENTS; HEALTH SERVICES ACCESSIBILITY; HEPATITIS C, CHRONIC; HUMANS; PATIENT EDUCATION; PREJUDICE; PRIMARY HEALTH CARE; PROFESSIONAL-PATIENT RELATIONS;

EID: 34250316905     PISSN: 00333549     EISSN: 14682877     Source Type: Journal    
DOI: 10.1177/00333549071220s215     Document Type: Review

References (46)

1. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006;144:705-14.
2. Edlin BR, Carden MR. Injection drug users: the overlooked core of the hepatitis C epidemic. Clin Infect Dis 2006;42:673-6. Also available from: URL: http://www.journals.uchicago.edu/cgi-bin/resolve?id=doi:10.1086/499960 [cited 2007 Jan 3].
3. National Center for Health Statistics. Plan and operation of the third National Health and Nutrition Examination Survey, 1988-94. Vital Health Stat 1994;1:1-416. Also available from: URL: http://www.cdc.gov/nchs/data/series/ sr_01/sr01_032.pdf [cited 2007 Jan 3].
4. Glynn M, Rhodes P. Estimated HIV prevalence in the United States at the end of 2003. National HIV Prevention Conference; 2005 Jun 12-15; Atlanta, Georgia. Abstract 595. Also available from: URL: http://www.aegis.com/ conferences/NHIVPC/2005/T1-B1101.pdf [cited 2007 Jan 3].
5. Wasley A, Finelli L, Bell BP, Alter MJ. The knowledge and behaviors of HCV-infected persons identified in a seroprevalence survey, United States, 2001-2002. Abstract [Poster 445] presented at 12th International Symposium on Viral Hepatitis And Liver Disease; 2006 Jul 1-5; Paris, France.
6. Poynard T, Cacoub P, Ratziu V, Myers RP, Dezailles MH, Mercadier A, et al. Fatigue in patients with chronic hepatitis C. J Viral Hepat 2002;9:295-303.
7. Rodger AJ, Jolley D, Thompson SC, Lanigan A, Crofts N. The impact of diagnosis of hepatitis C virus on quality of life. Hepatology 1999;30:1299-301.
8. Hussain KB, Fontana RJ, Moyer CA, Su GL, Sneed-Pee N, Lok AS. Comorbid illness is an important determinant of health-related quality of life in patients with chronic hepatitis C. Am J Gastroenterol 2001;96:2737-44.
9. Forton DM, Taylor-Robinson SD, Thomas HC. Reduced quality of life in hepatitis C-is it all in the head? J Hepatol 2002;36:435-8.
10. Zickmund S, Ho EY, Masuda M, Ippolito L, LaBrecque DR. "They treated me like a leper." Stigmatization and the quality of life of patients with hepatitis C. J Gen Intern Med 2003;18:835-44.
11. Golden J, Conroy RM, O'Dwyer AM, Golden D, Hardouin JB. Illness-related stigma, mood and adjustment to illness in persons with hepatitis C. Soc Sci Med 2006;63:3188-98.
12. Feld JJ, Liang TJ. Hepatitis C - identifying patients with progressive liver injury. Hepatology 2006;43:S194-206.
13. Heller T, Seeff LB. Viral load as a predictor of progression of chronic hepatitis C? Hepatology 2005;42:1261-3.
14. McHutchison JG, Bartenschlager R, Patel K, Pawlotsky JM. The face of future hepatitis C antiviral drug development: recent biological and virologic advances and their translation to drug development and clinical practice. J Hepatol 2006;44:411-21.
15. Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-36.
16. O'Connell JJ, Quick PD, Zevin BD. Documenting disability: simple strategies for medical providers. Post PA, editor. Nashville (TN): Health Care for the Homeless Clinicians' Network, National Health Care for the Homeless Council, Inc.; 2004.
17. Sylvestre DL, Loftis JM, Hauser P, Genser S, Cesari H, Borek N, et al. Co-occurring hepatitis C, substance use, and psychiatric illness: treatment issues and developing integrated models of care. J Urban Health 2004;81:719-34.
18. Schiff GD, Kim S. Case management/multidisciplinary care models. In: King TE, Wheeler MB, Fernandez A, Schillinger D, Bindman A, Grumbach K, et al., editors. Medical management of vulnerable and underserved patients: principles, practice, and populations. New York: McGraw-Hill; 2007. p. 151-8.
19. McGinn TG, Gardenier D, McGinn LK, Alfandre D, O'Connor-Moore N, Sturm TM, et al. Treating chronic hepatitis C in the primary care setting. Semin Liver Dis 2005;25:65-71.
20. Shehab TM, Orrego M, Chunduri R, Lok AS. Identification and management of hepatitis C patients in primary care clinics. Am J Gastroenterol 2003;98:639-44.
21. Clark EC, Yawn BP, Galliher JM, Temte JL, Hickner J. Hepatitis C identification and management by family physicians. Fam Med 2005;37:644-9.
22. Shehab TM, Sonnad SS, Lok AS. Management of hepatitis C patients by primary care physicians in the USA: results of a national survey. J Viral Hepat 2001;8:377-83.
23. Strader DB, Wright T, Thomas DL, Seeff LB; American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004;39:1147-71.
24. Sarrazin C, Teuber G, Kokka R, Rabenau H, Zeuzem S. Detection of residual hepatitis C virus RNA by transcription-mediated amplification in patients with complete virologic response according to polymerase chain reaction-based assays. Hepatology 2000;32:818-23.
25. Di Bisceglie AM, George SL, Mihindukulasuriya KL, Hoffmann J, Brunt EM, Bacon BR. [Poster 337] Clinical, biochemical, virologic and histologic outcomes of chronic hepatitis C following sustained virologic response (SVR) to HCV therapy: a prospective 5 year cohort study. 57th Annual Meeting of the American Association for the Study of Liver Diseases; 2006 Oct 27-31; Boston, Massachusetts. Also available from: URL: http://www.posters2view.com/aasld06/ view.php?nu=337 [cited 2007 Jan 3].
26. Hagan H, Campbell J, Thiede H, Strathdee S, Ouellet L, Kapadia F, et al. Self-reported hepatitis C virus antibody status and risk behavior in young injectors. Public Health Rep 2006;121:710-9.
27. Morrill JA, Shrestha M, Grant RW. Barriers to the treatment of hepatitis C. Patient, provider, and system factors. J Gen Intern Med 2005;20:754-8.
28. Hagan H, Latka MH, Campbell JV, Golub ET, Garfein RS, Thomas DA, et al. Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities. Clin Infect Dis 2006;42:669-72.
29. Fishbein DA, Lo Y, Reinus JF, Gourevitch MN, Klein RS. Factors associated with successful referral for clinical care of drug users with chronic hepatitis C who have or are at risk for HIV infection. J Acquir Immune Defic Syndr 2004;37:1367-75.
30. Edlin BR, Kresina TF, Raymond DB, Carden MR, Gourevitch MN, Rich JD, et al. Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. Clin Infect Dis 2005;40 Suppl 5:S276-85.
31. Arora S, Thornton K, Jenkusky SM, Parish B, Scaletti JV. Project ECHO: linking university specialists with rural and prison-based clinicians to improve care for people with chronic hepatitis C in New Mexico. Public Health Rep 2007;122(Suppl 2):74-7.
32. Yozviak JL, Vasiliadis E, Kimmel SR, Templer SJ, Hoffman-Terry M. A survey of primary care residents regarding knowledge of hepatitis C. [Poster 254] 57th Annual Meeting of the American Association for the Study of Liver Diseases; 2006 Oct 27-31, Boston, Massachusetts. Also available from: URL: http://www.posters2view.com/aasld06/view.php?nu=254 [cited 2007 Jan 3].
33. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005;5:558-67.
34. Ong JP, Collantes R, Pitts A, Martin L, Sheridan M, Younossi ZM. High rates of uninsured among HCV-positive individuals. J Clin Gastroenterol 2005;39:826-30.
35. Baldy LM, Urbas C, Harris JL, Jones TS, Reichert PE. Establishing a viral hepatitis prevention and control program: Florida's experience. Public Health Rep 2007;122(Suppl 2):24-30.
36. Subiadur J, Harris JL, Rietmeijer CA. Integrating viral hepatitis prevention services into an urban STD clinic: Denver, Colorado. Public Health Rep 2007;122(Suppl 2):12-7.
37. Heseltine G, McFarlane J. Texas statewide hepatitis C counseling and testing, 2000-2005. Public Health Rep 2007;122(Suppl 2):6-11.
38. Zimmerman R, Finley C, Rabins C, McMahon K. Integrating viral hepatitis prevention into STD clinics in Illinois (excluding Chicago), 1999-2005. Public Health Rep 2007;122(Suppl 2):18-23.
39. Zucker BL, Hauser P. Integrated care models for HCV+ veterans with co-morbid psychiatric and substance-use disorders. National Viral Hepatitis Prevention Conference; 2005 Dec 5-9; Washington, DC.
40. Loftis JM, Hauser P. Hepatitis C in patients with psychiatric disease and substance abuse: screening strategies and comanagement models of care. Curr Hepatitis Rep 2003;2:93-100.
41. Health Resources and Services Administration (US). Ryan White CARE Act [cited 2006 Oct 20]. Available from: URL: http://hab.hrsa.gov/history.htm
42. Clanon KA, Mueller JJ, Harank M. Integrating treatment for hepatitis C virus infection into an HIV clinic. Clin Infect Dis 2005:40(Suppl 5):S362-6.
43. Zevin B. Taking on hepatitis C in San Francisco. National Viral Hepatitis Prevention Conference; 2005 Dec 5-9; Washington, DC.
44. Rudman M. Taking on hepatitis C in Maryland. National Viral Hepatitis Prevention Conference; 2005 Dec 5-9; Washington, DC.
45. Grant WC, Jhaveri RR, McHutchison JG, Schulman KA, Kauf TL. Trends in health care resource use for hepatitis virus infection in the United States. Hepatology 2005;42:1406-13. Also available from: URL: http://www.interscience. wiley.com/jpages/0270-9139/suppmat/index.html [cited 2007 Jan 3].
46. Health Resources and Services Administration (US). Education and Training: AIDS Education and Training Centers [cited 2006 Oct 20]. Available from: URL: http://hab.hrsa.gov/educating.htm